IBC is led by world-leading clinical experts in the field of MGUS/SMM, MBL-CLL/Low-grade Lymphoma and CHIP/MDS/AML, who have put together a comprehensive agenda covering novel therapeutic strategies, addressing frontline challenges and optimizing patient care.

The workshop features presentations from an invited faculty of highly-respected clinicians and researchers around the world, followed by opportunities for Q&A panel discussions following each topic session.

The success of the IBC meeting will in no small part be due to the support of sponsors, allowing a unique opportunity for clinicians to be brought together to facilitate interactive and stimulating debates to help improve patient outcomes.